In the News
Press Release: The FDA Group Ranks No. 294 on the 2015 Inc. 500|5000 List
Process
The Section 513(g) Mechanism Explained
Process
What to Consider When Designing Human Factor Studies
Process
How the Orphan Drug Act Offsets Treatment Development Costs
Process
4 Important Features of Compliance Training Systems
Process
What is an Investigational Device Exemption?
FDA regulatory consultants
3 Advantages of Working with an FDA Consulting Firm
Medical Devices
A Basic Guide to the Medical Device Single Audit Program
In the News
What You Should Know About Compounding Pharmacy Laws
The FDA Group sets itself apart from traditional consulting firms through its client success and satisfaction rate, and its dedication to the life sciences.
